Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2023 on Wednesday, February 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialing (877) 502-9276 (in the United States and Canada) or +1 (773)-305-6867 (for international callers) and referencing access code 3278967. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. A webcast replay will be available approximately two hours after the call ends.
Hologic will provide a live and replay webcast of the call on the Company’s website at https://investors.hologic.com. The call will be available there for 30 days.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
SOURCE: Hologic, Inc.
| Last Trade: | US$73.89 |
| Daily Change: | -0.04 -0.05 |
| Daily Volume: | 6,816,065 |
| Market Cap: | US$16.430B |
October 21, 2025 October 02, 2025 September 26, 2025 September 03, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
